Literature DB >> 30929010

In Vitro Granuloma Models of Tuberculosis: Potential and Challenges.

Paul Elkington1, Maria Lerm2, Nidhi Kapoor3, Robert Mahon4, Elsje Pienaar5, Dongeun Huh6, Deepak Kaushal7, Larry S Schlesinger7.   

Abstract

Despite intensive research efforts, several fundamental disease processes for tuberculosis (TB) remain poorly understood. A central enigma is that host immunity is necessary to control disease yet promotes transmission by causing lung immunopathology. Our inability to distinguish these processes makes it challenging to design rational novel interventions. Elucidating basic immune mechanisms likely requires both in vivo and in vitro analyses, since Mycobacterium tuberculosis is a highly specialized human pathogen. The classic immune response is the TB granuloma organized in three dimensions within extracellular matrix. Several groups are developing cell culture granuloma models. In January 2018, NIAID convened a workshop, entitled "3-D Human in vitro TB Granuloma Model" to advance the field. Here, we summarize the arguments for developing advanced TB cell culture models and critically review those currently available. We discuss how integrating complementary approaches, specifically organoids and mathematical modeling, can maximize progress, and conclude by discussing future challenges and opportunities.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  granuloma; tissue culture models; tuberculosis

Mesh:

Year:  2019        PMID: 30929010      PMCID: PMC6534193          DOI: 10.1093/infdis/jiz020

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  54 in total

Review 1.  Microengineering of cellular interactions.

Authors:  A Folch; M Toner
Journal:  Annu Rev Biomed Eng       Date:  2000       Impact factor: 9.590

Review 2.  Microengineered physiological biomimicry: organs-on-chips.

Authors:  Dongeun Huh; Yu-suke Torisawa; Geraldine A Hamilton; Hyun Jung Kim; Donald E Ingber
Journal:  Lab Chip       Date:  2012-05-03       Impact factor: 6.799

3.  A mathematical representation of the development of Mycobacterium tuberculosis active, latent and dormant stages.

Authors:  Gesham Magombedze; Nicola Mulder
Journal:  J Theor Biol       Date:  2011-09-29       Impact factor: 2.691

4.  Human lung tissue engineering: a critical tool for safer medicines.

Authors:  Kelly BéruBé; Claire Gibson; Claire Job; Zoë Prytherch
Journal:  Cell Tissue Bank       Date:  2010-09-08       Impact factor: 1.522

5.  The Extracellular Matrix Regulates Granuloma Necrosis in Tuberculosis.

Authors:  Basim Al Shammari; Takayuki Shiomi; Liku Tezera; Magdalena K Bielecka; Victoria Workman; Tarangini Sathyamoorthy; Francesco Mauri; Suwan N Jayasinghe; Brian D Robertson; Jeanine D'Armiento; Jon S Friedland; Paul T Elkington
Journal:  J Infect Dis       Date:  2015-02-12       Impact factor: 5.226

6.  A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection.

Authors:  Clara Braian; Mattias Svensson; Susanna Brighenti; Maria Lerm; Venkata R Parasa
Journal:  J Vis Exp       Date:  2015-10-05       Impact factor: 1.355

7.  A Bioengineered Three-Dimensional Cell Culture Platform Integrated with Microfluidics To Address Antimicrobial Resistance in Tuberculosis.

Authors:  Magdalena K Bielecka; Liku B Tezera; Robert Zmijan; Francis Drobniewski; Xunli Zhang; Suwan Jayasinghe; Paul Elkington
Journal:  mBio       Date:  2017-02-07       Impact factor: 7.867

8.  Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy.

Authors:  R M MCCUNE; R TOMPSETT
Journal:  J Exp Med       Date:  1956-11-01       Impact factor: 14.307

9.  Hypoxia and tissue destruction in pulmonary TB.

Authors:  Moerida Belton; Sara Brilha; Roido Manavaki; Francesco Mauri; Kuldip Nijran; Young T Hong; Neva H Patel; Marcin Dembek; Liku Tezera; Justin Green; Rachel Moores; Franklin Aigbirhio; Adil Al-Nahhas; Tim D Fryer; Paul T Elkington; Jon S Friedland
Journal:  Thorax       Date:  2016-05-31       Impact factor: 9.139

10.  Mass Spectrometric Identification of Urinary Biomarkers of Pulmonary Tuberculosis.

Authors:  Flonza Isa; Sean Collins; Myung Hee Lee; Diessy Decome; Nancy Dorvil; Patrice Joseph; Lauren Smith; Stephen Salerno; Martin T Wells; Steven Fischer; James M Bean; Jean W Pape; Warren D Johnson; Daniel W Fitzgerald; Kyu Y Rhee
Journal:  EBioMedicine       Date:  2018-04-22       Impact factor: 8.143

View more
  20 in total

1.  A Mouse Model for Tuberculosis Combined With Inhalable Imiquimod-PLGA Nanocomposite Particles Based on Macrophage Phenotype.

Authors:  Teruki Nii; Shunsuke Takizawa; Tomomi Akita; Chikamasa Yamashita; Issei Takeuchi; Kimiko Makino
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

2.  Disease Models: Lung Models for Testing Drugs Against Inflammation and Infection.

Authors:  Patrick Carius; Justus C Horstmann; Cristiane de Souza Carvalho-Wodarz; Claus-Michael Lehr
Journal:  Handb Exp Pharmacol       Date:  2021

3.  Reconsidering the Optimal Immune Response to Mycobacterium tuberculosis.

Authors:  Liku B Tezera; Salah Mansour; Paul Elkington
Journal:  Am J Respir Crit Care Med       Date:  2020-02-15       Impact factor: 21.405

Review 4.  The knowns and unknowns of latent Mycobacterium tuberculosis infection.

Authors:  W Henry Boom; Ulrich E Schaible; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

Review 5.  Mycobacterium tuberculosis Infection-Driven Foamy Macrophages and Their Implications in Tuberculosis Control as Targets for Host-Directed Therapy.

Authors:  Dahee Shim; Hagyu Kim; Sung Jae Shin
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

Review 6.  Current concepts in granulomatous immune responses.

Authors:  Melinda Herbath; Zsuzsanna Fabry; Matyas Sandor
Journal:  Biol Futur       Date:  2021-02-25

7.  Tuberculosis lymph node granulomas: using transcriptomics to discover immunopathology paradigms and guide host-directed therapy.

Authors:  James J Phelan; Seónadh O'Leary; Joseph Keane
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 19.456

8.  Mycobacterium bovis Bacillus Calmette-Guérin-Infected Dendritic Cells Induce TNF-α-Dependent Cell Cluster Formation That Promotes Bacterial Dissemination through an In Vitro Model of the Blood-Brain Barrier.

Authors:  Trey E Gilpin; Fruzsina R Walter; Melinda Herbath; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2021-07-28       Impact factor: 5.426

9.  Mycobacteria-host interactions in human bronchiolar airway organoids.

Authors:  Nino Iakobachvili; Stephen Adonai Leon-Icaza; Kèvin Knoops; Norman Sachs; Serge Mazères; Roxane Simeone; Antonio Peixoto; Célia Bernard; Marlène Murris-Espin; Julien Mazières; Kaymeuang Cam; Christian Chalut; Christophe Guilhot; Carmen López-Iglesias; Raimond B G Ravelli; Olivier Neyrolles; Etienne Meunier; Geanncarlo Lugo-Villarino; Hans Clevers; Céline Cougoule; Peter J Peters
Journal:  Mol Microbiol       Date:  2021-11-05       Impact factor: 3.979

10.  Topologically correct synthetic reconstruction of pathogen social behavior found during Yersinia growth in deep tissue sites.

Authors:  Stacie A Clark; Derek Thibault; Lauren M Shull; Kimberly M Davis; Emily Aunins; Tim van Opijnen; Ralph Isberg
Journal:  Elife       Date:  2020-06-16       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.